News
Efficacy and safety of enlonstobart (SG001), a PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer: A multicenter, single-arm, open-label, phase II study. This is an ...
Efficacy and final safety analysis of pre- and co-administration of nivolumab (Nivo) with concurrent chemoradiation (CCRT) followed by Nivo maintenance therapy in patients (pts) with locally advanced ...
Chinese-American biopharmaceutical company Zai Lab has announced positive topline results from the China-specific arm in its Phase III innovaTV-301 study examining its antibody-drug conjugate (ADC) ...
Chinese doctors have saved a patient whose head was nearly severed by a robotic arm. Doctors said the patient’s cervical vertebrae had been severed and crucial neurovascular structures had been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results